“Low Dose Naltrexone (LDN) is a drug that is credited with helping those with HIV/AIDS, cancer, autoimmune diseases, and central nervous system disorders (including MS) by boosting the immune system. As well as being effective it is cheap, costing less than one pound a day, and could save the NHS vast sums of money. We therefore urge the Govenment to fund a trial of LDN on the NHS so that everyone in the UK can reap the benefits of this drug.”
LDN is not a miracle drug as many seem determined to claim, it is in fact a drug that implements the biotherapy approach to medicine, which is all about artificially stimulating the bodies own defenses and systems in order to restore control over systemic diseases. This control is how most people remain clear of these diseases in normal health. The immune system we have has evolved over billions of years and does many jobs far better than our modern, symptom relief drug culture ever can.
Go to the science if you really want to know about LDN at LDNScience.org. This is the site from the top scientists in the LDN sphere and now, hopefdully, we can dissolve the urban myths that the internet seems to breed.
Please sign the EU petition. We overloaded their email system by their email method so we've got a site based petition at last. They do ask for a donation after signing but I just ignored it. The EU petition takes this issue to the point about human rights. We feel that a person who requests LDN as a safe option should be able to get it easily. It is often the sick themselves who know what they need. But we also request that they make the research a reality, not just a notion assuming someone will do it eventually.
The application for research at NIHR has been considered and they apparently got no positive feedback from the NHS and couldn't find enough positive evidence on pubmed. We were restricted to 4 pages to summarise the thousand or so pages of science and were not allowed further input. Their rejection suggests to us that either they are just ignorant of the research and science and widespread use of LDN already, or that they are acting in a political manner. So, please feel free to send an email to NIHR and ask them for details of what evidence they considered, who decided and what was said. NIHR has a policy of openness and transparency so they have to respond top you. We can let them feel the demand now.
NEW Sam Blyth, youngest ever to be diagnosed with MS supports the LDNNow campaign. His story can be found on the MSRC website . His mother Sandra explains her frustration about LDN not being offered as a front line, first do no harm, option. LDNNow wishes Sam a great new year and all the support he needs to overcome his MS. It is very much for people like Sam that we need research and licensing of LDN on the NHS as a matter of urgency, and we look forward to a positive response from NIHR when they respond fully on 3rd March 2010, on our request to them for research in their Health Technology Assessment programme.
The petition - PETITION LINK , in one year, has achieved 13028 signatures demanding that the government funds the trials for Low Dose Naltrexone for the diseases that it treats if that is what is required to make it available on the NHS as a front line, 'first do no harm' treatment option, or persuade MHRA and NICE to just tell the GP's that it is a legitimate treatment for these uses and that they needn't fear litigation any more than they do for the risky therapies that abound for diseases like CANCER, MS, RHEUMATOID ARTHRITIS, HIV/AIDS and Autoimmune conditions in general and even INFERTILITY requiring IVF! and more besides.
We shall however continue to collect signatures. Download and print the petition form at link and add your name and any others available, then send it to our address as shown in the pamphlet below this.
Dr Chris Steele MBE from ITV 'This Morning" supports the LDN petition on YouTube, seen here handing in the petition to number 10 Downing Street with 13028 signatures. The response once again points us at the government sponsored body NIHR Health Technology Assessment programme, a body established to fund and pursue research which cannot find funding commercially. NIHR is about to judge on the LDNNow submission for research on the 19th January 2010, which has asked for research with a lot of emphasis on use as a front line, first do no harm, and safe therapy, for use with Cancer and autoimmune diseases. The Cancer use is critical with so many people suffering from Cancer in the UK, but diseases like MS, HIV/Aids, Crohns and Ulcerative Colitis, Rheumatoid Arthritis and even Infertility in women and the multitude of other autoimmune conditions that blight so many lives only add to the forceful nature of the case for research into this versatile therapy. As versatile as steroids, but without the bad side effects! Remember, first of all, LDN is safe, and if a strengthened immune system was a problem to people with autoimmune diseases, then how come all us LDN users are doing so well?
NEW Sam Blyth, youngest ever to be diagnosed with MS supports the LDNNow campaign. His story can be found on the 